U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Mar-14-2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Jul-14-2023 | CANCELLED SECTION 71 | C71TO | |
May-12-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Feb-24-2017 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Feb-24-2017 | FINAL DISPOSITION PROCESSED | FIMPP | |
Feb-02-2017 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jan-03-2017 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Oct-18-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Sep-28-2016 | NOTICE OF PUBLICATION | NPUBO | |
Sep-07-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Sep-06-2016 | ASSIGNED TO EXAMINER | DOCKD | |
Aug-26-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Aug-22-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Aug-18-2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Aug-18-2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |